HCP Roundtable: Critical Clinical Trial Conversations in the Expanding Myeloma Landscape
HCP Roundtable: Critical Clinical Trial Conversations in the Expanding Myeloma Landscape
Treatment options for multiple myeloma have increased substantially, mainly attributed to advancements in clinical trials. More than ever, HCPs having conversations about trials is critical. Given that underrepresented communities bear a disproportionate burden of multiple myeloma, it becomes imperative to shift this paradigm. What are the optimal approaches to initiate these conversations early in the […]